Literature DB >> 33624927

Aerosol transmission of SARS-CoV-2 by children and adults during the COVID-19 pandemic.

Peter P Moschovis1, Lael M Yonker1, Jhill Shah1, Dilpreet Singh2, Philip Demokritou2, T Bernard Kinane1.   

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be transmitted via respiratory droplets, aerosols, and to a lesser extent, fomites. Defining the factors driving infectivity and transmission is critical for infection control and containment of this pandemic. We outline the major methods of transmission of SARS-CoV-2, focusing on aerosol transmission. We review principles of aerosol science and discuss their implications for mitigating the spread of SARS-CoV-2 among children and adults.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; aerosol; face mask; transmission

Mesh:

Substances:

Year:  2021        PMID: 33624927      PMCID: PMC8014227          DOI: 10.1002/ppul.25330

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


INTRODUCTION

Coronavirus disease 2019 (COVID‐19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), was first described in Wuhan, China and rapidly spread across the world within weeks. , , Defining the factors driving the infectivity and transmission of SARS‐CoV‐2 has become critical for infection control and containment of this pandemic. Like other respiratory viruses, SARS‐CoV‐2 can be transmitted in three ways: droplets, aerosols, and contact with surfaces (fomites).

PRINCIPLES OF AEROSOL SCIENCE

The first two modes of transmission involve exhalation of viral particles from the respiratory tract (see Figure 1). Large particles (droplets) are subject to gravitational forces and typically land within a few feet of the subject and removed from the air quickly, while smaller particles (aerosols) remain suspended in air for longer and can travel much further. When inhaled, larger particles are trapped in the upper airways, while smaller particles deposit in the lower respiratory tract. The World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) classify particles with a diameter greater than 5 μm as droplets and those ≤5 μm as aerosols. , However, particles up to 20 μm with favorable aerodynamic characteristics (density, shape, etc.) and low settling velocity can linger for longer periods, behaving as suspended aerosols. , , Even large particles emitted from the nose or mouth can evaporate very quickly, decreasing their size and transforming into aerosols (a “droplet nucleus”).
Figure 1

Mechanisms of droplet, aerosol, and fomite transmission of SARS‐CoV‐2. SARS‐CoV‐2, severe acute respiratory syndrome coronavirus 2 [Color figure can be viewed at wileyonlinelibrary.com]

Mechanisms of droplet, aerosol, and fomite transmission of SARS‐CoV‐2. SARS‐CoV‐2, severe acute respiratory syndrome coronavirus 2 [Color figure can be viewed at wileyonlinelibrary.com] The characteristics of the indoor environment (i.e., size/volume, ventilation rate, and heating ventilation and air conditioning systems) into which aerosols are dispersed are also critical. In confined spaces with limited ventilation, the concentration of aerosols can remain high, facilitating transmission. Understanding droplet and aerosol dynamics and their link to built environment characteristics is critical in mitigating the spread of airborne infectious diseases. Much of the early work on aerosolized viral transmission dates to the early 20th century, when the spread of respiratory infections among school children and workers was investigated. As early as 1897, the German bacteriologist Carl Flügge noted that respiratory pathogens were present in expiratory droplets that settled around an individual, a finding that led to the development of surgical gauze masks. In 1945, J. P. Duguid studied characteristics of droplets and aerosols from humans during expiratory activities; he found that nasal exhalation sheds primarily droplets, with a minimal amount of aerosols. By contrast, talking, coughing, and sneezing produced more aerosols than droplets, primarily from the mouth. The mechanism of droplet production differs between the upper and lower airways, and these airway dynamics vary with age. In the upper airway, airflow and shear stress sweep excess airway lining fluid into a wave, and the resulting surface instability at the mucus‐air interface breaks the fluid wave into smaller droplets. Formation of wave instability (and therefore droplet production) depends on mucus thickness, viscoelastic properties, surface tension at the mucus‐air interface, and attaining a critical airspeed. Coughing and sneezing generate high airspeeds and can cause droplet formation via wave instability. During tidal breathing, however, the shear force provided by the low‐velocity airflow is insufficient to create droplets via wave instability. However, droplets can be formed during tidal breathing during the closing and reopening of collapsed terminal airways at low lung volumes; these small particles (<1 μm) are formed in the terminal bronchioles and are exhaled as aerosols. These mechanisms have special relevance to transmission of SARS‐CoV‐2 by children. Though children can carry a SARS‐CoV‐2 viral load that is greater than that of adults , and can transmit infection, , they may be less efficient transmitters than adults. Young children have a simpler airway structure (fewer alveoli and terminal bronchioles), lower exhaled airspeed, and less airway collapse than older children and adults. , Among adults, a positive association has been demonstrated between breath aerosol concentration and age, likely related to age‐related airway collapse. , Understanding the differences in droplet and aerosol formation across the lifecourse is a critical knowledge gap that requires further study. Once exhaled, the fate of aerosols and droplets is affected by evaporation, Brownian motion, electrostatic forces, inertial forces, the temperature, and humidity of the surrounding air, and gravity. , The risk of infection from aerosols is directly related to particle concentration, which is affected by the balance between production (affected by biological factors and patient density in a room) and elimination. Exhaled particles are subjected to two competing forces, gravity downwards and air friction upwards, and the balance of the two and cross‐flows determine the buoyancy of a particle. , Factors, such as doors, windows, human movement, ceiling fans, and heating, ventilation and air conditioning systems, as well as the direction of ventilation, can affect the buoyancy and travel of particles.

TRANSMISSION OF SARS‐CoV‐2 VIA RESPIRATORY DROPLETS AND AEROSOLS

As the major reservoir of the SARS‐CoV‐2 virus, the airway and nasal passages of infected individuals shed infectious droplets and aerosols that are not only created by “aerosol‐generating procedures,” but also by coughing, sneezing, breathing, or even simply talking. , Factors affecting potential for transmission include droplet size, viral load per droplet, and quantity and duration of droplet exposure. Large droplets fall nearby under the influence of gravity and contaminate surfaces, leading to fomite transmission. , Smaller droplets form aerosols that linger in the air for prolonged periods of time with the potential to travel greater distances, posing a greater risk of spreading COVID‐19. The minimum infectious dose (ID50, the dose that causes infection in 50% of hosts) for SARS‐CoV‐2 has not been established, though the ID50 for SARS‐CoV (the original SARS virus) is estimated at 280 plaque forming units. Each SARS‐CoV‐2 virion is approximately 50–200 nm in diameter; aerosolized particles of less than 5 µm (1 μm, or micron equals 1000 nm) potentially harbor several viral particles and can remain airborne for several hours. A laboratory study of nebulized SARS‐CoV‐2 demonstrated that the virus retains structural integrity for up to 16 h in respirable‐sized aerosols, longer than either SARS‐CoV or Middle East respiratory syndrome coronavirus ; another laboratory study demonstrated that viable virus can be recovered for at least three hours from aerosols sprayed into a closed non‐ventilated room. Early in the pandemic, droplets were thought to be the dominant method of disease transmission, despite research suggesting the original SARS‐CoV outbreak was spread by aerosols. , Multiple reports of aerosolized spread of COVID‐19 have been published since then, leading both the WHO and CDC to highlight the importance of aerosol transmission. , , , One of the first studies to suggest aerosol transmission of SARS‐CoV‐2 came from Inner Mongolia where a case of COVID‐19 appeared to result from regularly passing by the door of an asymptomatic patient. Airborne transmission was also likely responsible for an outbreak during a bus ride in China, in which one individual infected 23 of 67 passengers, including those seven rows behind the index case. Multiple outbreaks among adjacent tables in restaurants have also been reported. , Within the healthcare environment, one study found SARS‐CoV‐2 on air exhaust vent surfaces in patient rooms. A second study sampled air throughout inpatient wards, at least 2 m from patient beds, and recovered viral particles in 2 of 14 samples. A third study collected air samples in hospital rooms of COVID‐19 patients, and isolated viable virus in aerosols in the absence of aerosol generating procedures between 2 and 4.8 m from patients' beds. Additional outbreaks have been reported related to choir rehearsals, consistent with increased production of aerosols due to loud speech and singing. , , Taken together, these data suggest that infectious aerosols are commonly produced by patients infected with SARS‐CoV‐2, and that exposure to aerosolized virus in an indoor space for a prolonged period may carry significant risk which is underappreciated. Many routine pulmonary procedures have the potential of aerosol generation. Nebulized therapies are classified as a “possible aerosol generating procedure” by the CDC based on conflicting data from the SARS‐CoV epidemic. , Given this uncertainty, many hospitals and clinics treat nebulizer therapy as an aerosol generating procedure to protect healthcare providers from SARS‐CoV‐2 infection. Pulmonary function testing and spirometry are not currently classified as aerosol generating procedures by the CDC, though the American Thoracic Society and the American Academy of Asthma, Allergy, and Immunology recognize that pulmonary function testing has the potential to generate aerosols. , , , , , A small study of five adults undergoing pulmonary function testing demonstrated aerosol generation with tidal breathing, the forced vital capacity maneuver, and maximum voluntary ventilation, though additional studies are needed.

FOMITE TRANSMISSION

Fomite transmission requires contact with a contaminated surface followed by contact with a port of entry (eyes, mouth, nose). Viable SARS‐CoV‐2 can be recovered for at least 3 days after surfaces exposed to infected individuals. , , , , Though respiratory viruses can be transmitted via contact with surfaces, the relative contribution of fomites to SARS‐CoV‐2 transmission remains unknown. Two meta‐analyses of handwashing interventions before the COVID‐19 pandemic demonstrate that while hand hygiene is effective at reducing transmission of a range of respiratory viruses (including coronaviruses), it is less effective than mask use, providing indirect evidence that this is not the dominant mode of transmission for most respiratory viruses. ,

MITIGATING RISK OF TRANSMISSION

Simple measures are likely to significantly reduce the spread of droplets and aerosols. Masks (cotton, surgical, and N95) are very effective at limiting respiratory particle transmission during speaking and coughing (90% and 74%, respectively). , Masks reduce both inhalation and exhalation of droplets and aerosols, and are thus critical for interrupting transmission. , , , The efficacy of masks in reducing transmission depends on a variety of factors, including fit, time worn, and filtration efficacy. Higher filtration efficacy masks (e.g., N95 masks) are much more effective at filtration of aerosols than lower‐efficiency masks (e.g., surgical masks), , , but these do not currently exist in sizes for children and are poorly tolerated for long periods of time. The widely used spacing of 2 m is based on work by W. F. Wells, who pioneered the concept of aerosol‐transmitted infections in the 1930 s. Wells noted that large droplets (>100 μm) fall to the floor within 2 m from the source and are dispersed depending on the exhalation air velocity and relative humidity of the air. New models, though, demonstrate that with the flow rates of coughing and sneezing, droplets can travel up to 6 m, and patients with respiratory illness can generate a droplet cloud spanning up to 8 m. , Thus, social distancing is appropriate but no replacement for masks.

CONCLUSION

Droplets and aerosols are generated by tidal breathing, coughing, and sneezing. SARS‐CoV‐2 can be transmitted by all these methods and is viable in particles that remain suspended in air. Understanding the behavior of virus‐laden droplets and aerosols in confined spaces is urgently needed for schools and workplaces to open safely. This makes the usage of masks, social distancing, and adequate room ventilation critical for limiting the aerosol spread of SARS‐CoV‐2.

CONFLICT OF INTERESTS

The authors declare that there are no conflict of interests.

AUTHOR CONTRIBUTIONS

Peter Moschovis: conceptualization (equal); writing original draft (lead); writing review & editing (lead). Lael M Yonker: writing review & editing (supporting). Jhill Shah: writing review & editing (supporting). Dilpreet Singh: methodology (equal). Philip Demokritou: methodology (lead); writing original draft (supporting); writing review & editing (supporting). T Bernard Kinane: conceptualization (lead); writing original draft (equal); writing review & editing (equal).
  61 in total

1.  Environmental transmission of SARS at Amoy Gardens.

Authors:  Kelly R McKinney; Yu Yang Gong; Thomas G Lewis
Journal:  J Environ Health       Date:  2006-05       Impact factor: 1.179

2.  Turbulent Gas Clouds and Respiratory Pathogen Emissions: Potential Implications for Reducing Transmission of COVID-19.

Authors:  Lydia Bourouiba
Journal:  JAMA       Date:  2020-05-12       Impact factor: 56.272

3.  High SARS-CoV-2 Attack Rate Following Exposure at a Choir Practice - Skagit County, Washington, March 2020.

Authors:  Lea Hamner; Polly Dubbel; Ian Capron; Andy Ross; Amber Jordan; Jaxon Lee; Joanne Lynn; Amelia Ball; Simranjit Narwal; Sam Russell; Dale Patrick; Howard Leibrand
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-05-15       Impact factor: 17.586

4.  Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19).

Authors:  Taylor Heald-Sargent; William J Muller; Xiaotian Zheng; Jason Rippe; Ami B Patel; Larry K Kociolek
Journal:  JAMA Pediatr       Date:  2020-09-01       Impact factor: 16.193

5.  How far droplets can move in indoor environments--revisiting the Wells evaporation-falling curve.

Authors:  X Xie; Y Li; A T Y Chwang; P L Ho; W H Seto
Journal:  Indoor Air       Date:  2007-06       Impact factor: 5.770

6.  Development of a dose-response model for SARS coronavirus.

Authors:  Toru Watanabe; Timothy A Bartrand; Mark H Weir; Tatsuo Omura; Charles N Haas
Journal:  Risk Anal       Date:  2010-05-20       Impact factor: 4.000

7.  Environmental Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 During a COVID-19 Outbreak on the Diamond Princess Cruise Ship.

Authors:  Takuya Yamagishi; Makoto Ohnishi; Nobuaki Matsunaga; Kensaku Kakimoto; Hajime Kamiya; Kiyoko Okamoto; Motoi Suzuki; Yoshiaki Gu; Mikiyo Sakaguchi; Taichi Tajima; Saho Takaya; Norio Ohmagari; Makoto Takeda; Shuyoku Matsuyama; Kazuya Shirato; Naganori Nao; Hideki Hasegawa; Tsutomu Kageyama; Ikuyo Takayama; Shinji Saito; Koji Wada; Retsu Fujita; Hiroki Saito; Keiji Okinaka; Mathew Griffith; Amy Elizabeth Parry; Brenda Barnetson; James Leonard; Takaji Wakita
Journal:  J Infect Dis       Date:  2020-09-01       Impact factor: 5.226

8.  Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.

Authors:  Neeltje van Doremalen; Trenton Bushmaker; Dylan H Morris; Myndi G Holbrook; Amandine Gamble; Brandi N Williamson; Azaibi Tamin; Jennifer L Harcourt; Natalie J Thornburg; Susan I Gerber; James O Lloyd-Smith; Emmie de Wit; Vincent J Munster
Journal:  N Engl J Med       Date:  2020-03-17       Impact factor: 91.245

9.  COVID-19 may transmit through aerosol.

Authors:  Juan Wang; Guoqiang Du
Journal:  Ir J Med Sci       Date:  2020-03-24       Impact factor: 1.568

10.  Efficacy of masks and face coverings in controlling outward aerosol particle emission from expiratory activities.

Authors:  Sima Asadi; Christopher D Cappa; Santiago Barreda; Anthony S Wexler; Nicole M Bouvier; William D Ristenpart
Journal:  Sci Rep       Date:  2020-09-24       Impact factor: 4.379

View more
  6 in total

1.  Inactivating SARS-CoV-2 Surrogates on Surfaces Using Engineered Water Nanostructures Incorporated with Nature Derived Antimicrobials.

Authors:  Nachiket Vaze; Anand R Soorneedi; Matthew D Moore; Philip Demokritou
Journal:  Nanomaterials (Basel)       Date:  2022-05-19       Impact factor: 5.719

Review 2.  Nanocellulose-based membrane as a potential material for high performance biodegradable aerosol respirators for SARS-CoV-2 prevention: a review.

Authors:  Tido Tiwa Stanislas; Ketty Bilba; Rachel Passos de Oliveira Santos; Cristel Onésippe-Potiron; Holmer Savastano Junior; Marie-Ange Arsène
Journal:  Cellulose (Lond)       Date:  2022-08-17       Impact factor: 6.123

3.  Assessment of Surface Disinfection Effectiveness of Decontamination System COUNTERFOG® SDR-F05A+ Against Bacteriophage ɸ29.

Authors:  Cristina Del Álamo; Ángela Vázquez-Calvo; Antonio Alcamí; Juan Sánchez-García-Casarrubios; José Luis Pérez-Díaz
Journal:  Food Environ Virol       Date:  2022-07-19       Impact factor: 4.034

4.  Exhaled Aerosols in SARS-CoV-2 Polymerase Chain Reaction-Positive Children and Age-Matched-Negative Controls.

Authors:  Desiree Gutmann; Helena Donath; Laura Herrlich; Timon Lehmkühler; Anton Landeis; Emily R Ume; Martin Hutter; Ann-Kathrin Goßmann; Frederik Weis; Maximilian Weiß; Holger F Rabenau; Stefan Zielen
Journal:  Front Pediatr       Date:  2022-07-18       Impact factor: 3.569

5.  Definition of an Indoor Air Sampling Strategy for SARS-CoV-2 Detection and Risk Management: Case Study in Kindergartens.

Authors:  Laura Borgese; Giuseppe Tomasoni; Filippo Marciano; Annalisa Zacco; Fabjola Bilo; Elena Stefana; Paola Cocca; Diana Rossi; Paola Cirelli; Angelo Luigi Camillo Ciribini; Sara Comai; Silvia Mastrolembo Ventura; Michela Savoldi Boles; Diletta Micheletti; Daniela Cattivelli; Serena Galletti; Sophie Dubacq; Maria Grazia Perrone; Laura Eleonora Depero
Journal:  Int J Environ Res Public Health       Date:  2022-06-16       Impact factor: 4.614

Review 6.  Aerosol transmission of SARS-CoV-2 by children and adults during the COVID-19 pandemic.

Authors:  Peter P Moschovis; Lael M Yonker; Jhill Shah; Dilpreet Singh; Philip Demokritou; T Bernard Kinane
Journal:  Pediatr Pulmonol       Date:  2021-03-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.